RaymondEDe La RosaMD
Endocrinology • Englewood, FLDiabetes, Lipid Metabolism, Parathyroid, Thyroid
Physician
Dr. De La Rosa is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3000 S. McCall Rd
Englewood, FL 34224Phone+1 941-841-4200- Is this information wrong?
Summary
- Dr. Raymond de la Rosa is an Endocrinologist in Englewood, FL. A graduate of the University of the Philippines College of Medicine, he completed his residency in Internal Medicine at the Lutheran Medical Center (now NYU - Langone Hospital) and fellowship in Endocrinology, Diabetes and Metabolism at Brown University. Dr. de la Rosa has been in practice for over 24 years.
Education & Training
Brown UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 1993 - 1995
NYU Grossman School of Medicine/Brooklyn CampusResidency, Internal Medicine, 1990 - 1993
University of the Philippines College of MedicineClass of 1989
Certifications & Licensure
FL State Medical License 2017 - 2025
OR State Medical License 2019 - 2021
KY State Medical License 1994 - 2017
NC State Medical License 2004 - 2013
AR State Medical License 1998 - 2005
OK State Medical License 1998 - 2004
RI State Medical License 1993 - 1996- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013
Publications & Presentations
PubMed
- 2 citationsEffect of Insulin Degludec Versus Insulin Glargine U100 on Hypoglycemia in Hispanic Patients With Type 2 Diabetes: Results From the SWITCH 2 Trial.Louis B. Chaykin, Anuj Bhargava, Raymond de la Rosa, Carol Wysham, Lone Nørgård Troelsen, Signe H. Østoft, Athena Philis-Tsimikas> ;Clinical Diabetes. 2019 Jan 1
- 179 citationsSemaglutide Added to Basal Insulin in Type 2 Diabetes (SUSTAIN 5): A Randomized, Controlled Trial.Helena W. Rodbard, Ildiko Lingvay, John C. Reed, Raymond de la Rosa, Ludger Rose, Danny Sugimoto, Eiichi Araki, Pei Ling Chu, Nelun Wijayasinghe, Paul Norwood> ;The Journal of Clinical Endocrinology and Metabolism. 2018 Jun 1
- 167 citationsEffect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 2 Diabetes: The SWITCH 2 Randomized Clinical Trial.Carol Wysham, Anuj Bhargava, Louis B. Chaykin, Raymond de la Rosa, Yehuda Handelsman, Lone Nørgård Troelsen, Kajsa Kvist, Paul Norwood> ;JAMA. 2017 Jul 4
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
